🔎 Trials Near Me

Akèy › Maladi otoim › Oregon › Portland

Etid klinik pou Maladi otoim nan Portland, OR

8 etid pou Maladi otoim ap chèche patisipan nan sit nan ak bò kote Portland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • Oregon Health & Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ap rekriteFaz 2/3
  • Oregon Health & Science University - Accepting Adult Patients, Portland
Laj 6 a 75 · Tout sèks · Mizajou Sep 17, 2026 · NCT06154252

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Ap rekriteFaz 3
  • Oregon Health & Science University, Portland
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06948318

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Ap rekriteFaz 1/2
  • Oregon Health & Science University, Portland
Laj 18 a 70 · Tout sèks · Mizajou Aug 13, 2026 · NCT06359041

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Ap rekriteFaz 2/3
  • Oregon Health & Science University, Portland
Laj 18 a 75 · Tout sèks · Mizajou Jul 29, 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Oregon Health & Science University/Doernbecher Children's Hospital, Portland
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Ap rekriteFaz 1
  • Oregon Health Sciences University, Portland
Laj 18 a 70 · Tout sèks · Mizajou Jun 30, 2026 · NCT06201416

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Ap rekriteFaz 1
  • Oregon Health & Science University (OHSU), Portland
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT06626919

Etid Maladi otoim nan lòt vil

Lòt etid nan Portland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.